Syndax Pharmaceuticals, Inc.
NASDAQ:SNDX
21.52 (USD) • At close November 7, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -209.36 | -149.338 | 24.926 | -73.158 | -56.047 | -73.961 | -60.802 | -44.472 | -24.119 | -19.828 | -14.171 | -9.965 |
| Afschrijvingen & Amortisatie
| 0.012 | 0.033 | 0.043 | 0.089 | 0.092 | 0.078 | 0.076 | 0.089 | 0.021 | 0.015 | 0.013 | 0.034 |
| Uitgestelde Inkomstenbelasting
| -5.611 | 0 | 0.255 | -0.13 | -0.78 | -0.558 | 0.223 | 1.577 | 2.466 | 2.572 | 1.687 | -3.442 |
| Aandelen Gebaseerde Vergoedingen
| 30.951 | 16.019 | 13.317 | 9.057 | 6.005 | 6.201 | 5.45 | 4.708 | 3.882 | 2.257 | 1.415 | 0.139 |
| Verandering in Werkkapitaal
| 31.86 | 1.656 | -9.597 | -7.934 | -0.241 | -0.302 | 7.674 | 2.916 | 14.56 | 0.551 | 0.031 | 0.823 |
| Vorderingen
| 10.706 | -3.474 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| -10.706 | 3.474 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 5.611 | -1.319 | 2.161 | -2.67 | 4.739 | -0.792 | -0.194 | 0.923 | 1.045 | -0.726 | -0.286 | -0.035 |
| Overig Werkkapitaal
| 26.249 | 2.975 | -11.758 | -5.264 | -4.98 | 0.49 | 7.868 | 1.993 | 13.515 | 1.277 | 0.317 | 0.858 |
| Overige Niet-Contante Posten
| -8.453 | -2.045 | 0.187 | 0.816 | 0.359 | 0.011 | 0.008 | 0.025 | 0.762 | 0.04 | 3.73 | 3.127 |
| Kasstroom uit Operationele Activiteiten
| -160.601 | -133.675 | 29.131 | -71.26 | -50.612 | -68.531 | -47.371 | -35.157 | -2.428 | -14.393 | -7.295 | -9.284 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| 0 | -0.225 | -0.129 | 0 | 0 | -0.187 | -0.084 | -0.261 | -0.049 | -0.004 | -0.038 | -0.011 |
| Netto Overnames
| 0 | 0.225 | 0.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -354.606 | -495.346 | -294.719 | -278.937 | -104.018 | -78.844 | -152.263 | -158.319 | -102.008 | -3.393 | -4.022 | 0 |
| Verkoop/verval van Beleggingen
| 472.215 | 308.933 | 253.975 | 136.407 | 116.799 | 130.429 | 135.275 | 140.297 | 40.506 | 5.286 | 0 | 0.5 |
| Overige Investeringsactiviteiten
| 0.118 | 0.225 | -0.041 | -0.143 | 0.013 | 0.052 | 0.045 | -0.097 | -0.118 | -0.001 | 0.033 | 0.005 |
| Kasstroom uit Investeringsactiviteiten
| 117.609 | -186.188 | -40.873 | -142.53 | 12.781 | 51.398 | -17.027 | -18.38 | -61.669 | 1.888 | -4.027 | 0.494 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | -20.996 | 0 | -19.73 | 0 | 0 | 0 | 0 | -9.002 | -0.002 | -4.423 | -1.759 |
| Uitgifte van Gewone Aandelen
| 258.094 | 181.791 | 118.464 | 284.693 | 28.57 | 15.497 | 75.348 | 52.148 | 87.514 | 0.006 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 24.848 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.598 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 6.038 | 11.459 | 118.464 | 284.694 | 28.57 | 0.232 | 0.374 | 4.652 | 86.269 | 12.406 | 25.312 | 7.468 |
| Kasstroom uit Financieringsactiviteiten
| 264.132 | 172.254 | 118.464 | 304.424 | 28.57 | 15.729 | 75.722 | 54.202 | 77.267 | 12.41 | 20.889 | 5.709 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 221.14 | -147.609 | 106.722 | 90.634 | -9.261 | -1.404 | 11.324 | 0.665 | 13.17 | -0.095 | 9.567 | -3.081 |
| Kaspositie aan het Einde van de Periode
| 295.611 | 74.471 | 222.08 | 115.358 | 24.724 | 33.985 | 35.168 | 23.844 | 23.179 | 10.009 | 10.104 | 0.537 |